Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / Common Shares, no par value
Shares outstanding
132,929,348
Total 13F shares
6,743,443
Share change
+10,505
Total reported value
$19,673,000
Price per share
$2.92
Number of holders
16
Value change
+$25,044
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
NEA Management Company, LLC
13F
Company
1.9%
2,546,843
$6,291,000 31 Dec 2015
13F
GREAT POINT PARTNERS LLC
13F
Company
1.8%
2,457,144
$6,160,000 31 Dec 2015
13F
BAKER BROS. ADVISORS LP
13F
Company
0.54%
711,499
$1,789,000 31 Dec 2015
13F
EverPoint Asset Management, LLC
13F
Company
0.5%
659,210
$1,628,000 31 Dec 2015
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.11%
145,200
$359,000 31 Dec 2015
13F
Lombard Odier Asset Management (USA) Corp
13F
Company
0.09%
114,912
$284,000 31 Dec 2015
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
37,200
$92,000 31 Dec 2015
13F
UBS Group AG
13F
Company
0.01%
16,910
$42,000 31 Dec 2015
13F
Redmile Group, LLC
13F
Company
0.01%
16,610
$41,000 31 Dec 2015
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
10,843
$27,000 31 Dec 2015
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
7,767
$19,000 31 Dec 2015
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
7,500
$19,000 31 Dec 2015
13F
MORGAN STANLEY
13F
Company
0%
1,000
$2,000 31 Dec 2015
13F
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
13F
Company
0%
300
$741 31 Dec 2015
13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2016

As of 31 Mar 2016, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,743,443 shares. The largest 10 holders included NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, Abingworth LLP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, and Redmile Group, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders
14
Q1 2016 holders
16
Holder diff
2
Investor Q4 2015 Shares Q1 2016 Shares Share Diff Share Chg % Q4 2015 Value $ Q1 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.